FDA Adds Warning to Osteoporosis Drug for Hypocalcemia Risk
Based on a completed data review, the agency concluded that denosumab increases the risk for severe hypocalcemia in patients with chronic kidney disease.
Stay updated with breaking news from Vascular Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Based on a completed data review, the agency concluded that denosumab increases the risk for severe hypocalcemia in patients with chronic kidney disease.
Dialysis group Fresenius Medical Care said on Wednesday that data including medical records on 500,000 patients and former patients were stolen from a US subsidiary's data warehouse.
Clinicians should screen for changes in taste and smell among patients at risk for cognitive changes and offer nutritional interventions to support body weight and QOL.
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023 aXess demonstrated exceptional patency rates and no infections to date EINDHOVEN, The Netherlands – 17 November 2023, Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces outstanding 12-month data from its first-in-human (FIH) aXess vascular conduit trial (NCT04898153). The data was presen
BJN publication featuring VALGuard offers healthcare professionals essential Continuing Education Credits ...